4PBA has also been tested with the mutant channel Δ508-CFTR-inducing cell surface expression [278], and some clinical trials using this chemical chaperone in cystic fibrosis patients have demonstrated an improvement in CFTR function in the nasal epithelia [279]. Here, CFTR is linked to cystic fibrosis.